EUVIMEDEUVIMED entdecken
Crossref

Plasmodium proteases and their role in development of Malaria vaccines

Gunjan Arora, Jiří Černý

Advances in Parasitology · 2024

DOI: 10.1016/bs.apar.2024.08.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Parasitology, 2024. Verfasst von Gunjan Arora und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States. Electronic address: arorag198…. Hauptthemen laut MEDLINE: Malaria Vaccines, Peptide Hydrolases, Plasmodium, Protozoan Proteins. Die Arbeit nennt 124 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria remains a major health hazard for humans, despite the availability of efficacious antimalarial drugs and other interventions. Given that the disease is often deadly for children under 5 years and pregnant women living in malaria-endemic areas, an efficacious vaccine to prevent transmission and clinical disease would be ideal. Plasmodium, the causative agent of malaria, uses proteases and protease inhibitors to control and process to invade host, modulate host immunity, and for pathogenesis. Plasmodium parasites rely on these proteases for their development and survival, including feeding their metabolic needs and invasion of both mosquito and human tissues, and have thus been explored as potential targets for prophylaxis. In this chapter, we have discussed the potential of proteases like ROM4, SUB2, SERA4, SERA5, and others as vaccine candidates. We have also discussed the role of some protease inhibitors of plasmodium and mosquito origin. Inhibition of plasmodium proteases can interrupt the parasite development at many different stages therefore understanding their function is key to developing new drugs and malaria vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria VaccinesPeptide HydrolasesPlasmodiumProtozoan ProteinsAnimalsHumansMalariaProtease InhibitorsVaccine Development

Stichwörter der Autor:innen

Antimalarial drugsPlasmodiumProtease inhibitorsProteasesSerpinsVaccine developmentVaccinesVector-borne pathogens

Substanzen

Malaria VaccinesPeptide HydrolasesProtease InhibitorsProtozoan Proteins

Autor:innen und Institutionen

  • Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States. Electronic address: arorag1983@gmail.com.
  • Centre for Infectious Animal Diseases, Faculty of Tropical AgriSciences, Czech University of Life Sciences Prague, Prague-Suchdol, Czechia.

Zitieren

APA

Arora, G., & Černý, J. (2024). Plasmodium proteases and their role in development of Malaria vaccines. Advances in Parasitology. https://doi.org/10.1016/bs.apar.2024.08.001

Vancouver

Arora G, Černý J. Plasmodium proteases and their role in development of Malaria vaccines. Advances in Parasitology. 2024. doi:10.1016/bs.apar.2024.08.001

BibTeX
@article{Arora2024,
  author = {Arora, Gunjan and Černý, Jiří},
  title = {Plasmodium proteases and their role in development of Malaria vaccines},
  journal = {Advances in Parasitology},
  year = {2024},
  doi = {10.1016/bs.apar.2024.08.001}
}
Kostenlos starten →